Search Results - "Dinara G. Gusenbekova"

Cardiovascular risk and self-monitoring of blood glucose in patients with diabetes mellitus by Gusenbekova, Dinara G., Ostroumova, Olga D.

“…To date, the global spread of diabetes mellitus has gained alarming proportions. despite the broad spectrum of hypoglycemic drugs, diabetes mellitus is still…”
Get full text

Risk management of micro- and macrovascular complications of diabetes mellitus: the importance of glycemic self-control by Olga A. Polyakova, Dinara G. Gusenbekova, Olga D. Ostroumova

“…As the incidence of obesity, unhealthy lifestyles and an aging population increases, the global prevalence of diabetes mellitus (DM) is projected to rise…”
Get full text

INFLUENCE OF TYPE 2 SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS (DAPAGLIFLOZIN) ON THE INDICATORS OF TOTAL MORTALITY IN PATIENTS WITH TYPE 2 DIABETES (CARDIA-MOS STUDY, MOSCOW) by Mikhail B. Antsiferov, Nikolay A. Demidov, Maria A. Balberova, Olga V. Lobanova, Irina G. Mudrikova, Dinara G. Gusenbekova

“…BACKGROUND: Widespread clinical use of drugs with cardioprotective/nephroprotective properties – particularly sodium-glucose cotransporter type 2 inhibitors…”
Get full text

Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow) by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Lobanova, O. V., Mudrikova, I. G., Gusenbekova, D. G.

“…BACKGROUND: The widespread use in clinical practice of drugs with cardio- and nephroprotective properties, in particular, sodium-glucose cotransporter type 2…”
Get full text